2018 Australasian HIV&AIDS Conference

The Australasian HIV&AIDS Conference (28th Annual Conference of the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine) is the premier HIV Conference in Australia and the Asia and Pacific region.

Burnet research has played a significant role in the quest to combat HIV infection and AIDS in the region.

Among the presenters speaking at the conference are:

Professor Gilda Tachedjian: The influence of mucosal inflammation and microbiota metabolites on HIV transmission in women.

Dr Anna Hearps: Mechanisms driving increased atherosclerosis risk in people living with HIV on cART.

Michael Traeger: Changes In sexually transmitted infections among gay and bisexual men after enrolling in the PrEPX implementation study.

Jason Asselin: Segmented linear regression to assess HIV testing among Prepx and non-Prepx participants during rapid prep scale-up in Melbourne, Australia.

Brendan Harney: Sexualised drug use and co-occurring high risk behaviours among gay and bisexual men living with HIV/hepatitis C co-infection in Melbourne, Australia.

The annual conference is run by Australasian Society for HIV Medicine as a platform for the dissemination and presentation of new and innovative research findings across the Australasian HIV sector.

For more details go to the official Australasian HIV&AIDS Conference website.

Date & Time

Monday, 24 September, 2018 – Wednesday, 26 September, 2018


Sydney Masonic Centre
66 Goulburn St
Sydney NSW 2000

Google Map

Contact Details

For more information about this event, please contact:

Professor Mark A Stoové

Head of Public Health




[email protected]